{"organizations": [], "uuid": "af5d8ce015e18da42dee09fe08b3306f3f98e092", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180416.html", "section_title": "Archive News &amp; Video for Monday, 16 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-north-china-pharmaceutical-gets-ap/brief-north-china-pharmaceutical-gets-approval-to-issue-2-0-billion-yuan-commercial-paper-idUSH9N1RO028", "country": "US", "domain_rank": 408, "title": "BRIEF-North China Pharmaceutical Gets Approval To Issue 2.0 Billion Yuan Commercial Paper", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-04-16T21:11:00.000+03:00", "replies_count": 0, "uuid": "af5d8ce015e18da42dee09fe08b3306f3f98e092"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-north-china-pharmaceutical-gets-ap/brief-north-china-pharmaceutical-gets-approval-to-issue-2-0-billion-yuan-commercial-paper-idUSH9N1RO028", "ord_in_thread": 0, "title": "BRIEF-North China Pharmaceutical Gets Approval To Issue 2.0 Billion Yuan Commercial Paper", "locations": [], "entities": {"persons": [], "locations": [{"name": "hong kong", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "north china pharmaceutical co ltd", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 16 (Reuters) - North China Pharmaceutical Co Ltd :\n* SAYS IT GETS APPROVAL TO ISSUE 2.0 BILLION YUAN ($318.51 million) COMMERCIAL PAPER Source text in Chinese: bit.ly/2qzhBC4 Further company coverage: ($1 = 6.2792 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ", "external_links": ["https://twitter.com/reuters", "https://bit.ly/2qzhBC4", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-16T21:11:00.000+03:00", "crawled": "2018-04-17T12:26:29.000+03:00", "highlightTitle": ""}